News
20hon MSN
Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.
In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...
Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results